Norstella Launches Pipeline-to-Patient Productivity Index to Benchmark Biopharma Performance Across the Drug Development LifecycleUnusual Whales·Jul 28 at 10:42 AM
CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related DisorderUnusual Whales·Jul 27 at 06:03 AMCAMP-0.58%
Humacyte - CW27 | 10-Q: FY2025 Q3 Revenue: USD 753 KEarnings Watch·Nov 12, 2025 at 04:09 PMHUMAW+11.11%
Humacyte - CW27 | 8-K: FY2025 Q3 Revenue: USD 753 KEarnings Watch·Nov 12, 2025 at 06:08 AMHUMAW+11.11%
Humacyte - CW27 | 10-Q: FY2025 Q2 Revenue: USD 301 KEarnings Watch·Aug 11, 2025 at 04:03 PMHUMAW+11.11%
Humacyte - CW27 | 8-K: FY2025 Q2 Revenue: USD 301 KEarnings Watch·Aug 11, 2025 at 06:05 AMHUMAW+11.11%
Humacyte - CW27 | 10-Q: FY2025 Q1 Revenue: USD 517 KEarnings Watch·May 13, 2025 at 04:13 PMHUMAW+11.11%
Humacyte - CW27 | 8-K: FY2025 Q1 Revenue: USD 517 KEarnings Watch·May 13, 2025 at 06:37 AMHUMAW+11.11%
